Surgical and endovascular hybrid approach in peripheral arterial disease of the lower limbs.

Details

Serval ID
serval:BIB_16BC9E8C0FE6
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Surgical and endovascular hybrid approach in peripheral arterial disease of the lower limbs.
Journal
Vasa. Zeitschrift Für Gefässkrankheiten
Author(s)
Grandjean A., Iglesias K., Dubuis C., Déglise S., Corpataux J.M., Saucy F.
ISSN
0301-1526 (Print)
ISSN-L
0301-1526
Publication state
Published
Issued date
2016
Peer-reviewed
Oui
Volume
45
Number
5
Pages
417-422
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
BACKGROUND: Multilevel peripheral arterial disease is frequently observed in patients with intermittent claudication or critical limb ischemia. This report evaluates the efficacy of one-stage hybrid revascularization in patients with multilevel arterial peripheral disease.
PATIENTS AND METHODS: A retrospective analysis of a prospective database included all consecutive patients treated by a hybrid approach for a multilevel arterial peripheral disease. The primary outcome was the patency rate at 6 months and 1 year. Secondary outcomes were early and midterm complication rate, limb salvage and mortality rate. Statistical analysis, including a Kaplan-Meier estimate and univariate and multivariate Cox regression analyses were carried out with the primary, primary assisted and secondary patency, comparing the impact of various risk factors in pre- and post-operative treatments.
RESULTS: 64 patients were included in the study, with a mean follow-up time of 428 days (range: 4 - 1140). The technical success rate was 100 %. The primary, primary assisted and secondary patency rates at 1 year were 39 %, 66 % and 81 %, respectively. The limb-salvage rate was 94 %. The early mortality rate was 3.1 %. Early and midterm complication rates were 15.4 % and 6.4 %, respectively. The early mortality rate was 3.1 %.
CONCLUSIONS: The hybrid approach is a major alternative in the treatment of peripheral arterial disease in multilevel disease and comorbid patients, with low complication and mortality rates and a high limb-salvage rate.
Pubmed
Web of science
Create date
14/10/2016 15:35
Last modification date
20/08/2019 13:46
Usage data